Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule. |
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
ze3VcQqZUaTk7g3t
